ArticlePloS one2020

A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.

Macarena Sarli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.